Applied DNA Sciences, Inc. (NASDAQ:BNBX) — Market Cap & Net Worth
Market Cap & Net Worth: Applied DNA Sciences, Inc. (BNBX)
Applied DNA Sciences, Inc. (NASDAQ:BNBX) has a market capitalization of $720.44K ($720.44K) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30738 globally and #6152 in its home market, demonstrating a 22.07% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Applied DNA Sciences, Inc.'s stock price $0.10 by its total outstanding shares 7197228 (7.20 Million). Review BNBX total debt and obligations to assess the company's total debt and financial obligations.
Applied DNA Sciences, Inc. Market Cap History: 2025 to 2026
Applied DNA Sciences, Inc.'s market capitalization history from 2025 to 2026. Data shows growth from $8.85 Million to $720.44K (0.00% CAGR).
Applied DNA Sciences, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Applied DNA Sciences, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.14x
Applied DNA Sciences, Inc.'s market cap is 4.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $8.85 Million | $2.14 Million | -$15.16 Million | 4.14x | N/A |
Competitor Companies of BNBX by Market Capitalization
Companies near Applied DNA Sciences, Inc. in the global market cap rankings as of August 3, 2026.
Key companies related to Applied DNA Sciences, Inc. by market ranking:
- BlackRock Inc (NYSE:BLK): Ranked #135 globally with a market cap of $167.86 Billion USD.
- Brookfield Corporation (TO:BN): Ranked #266 globally with a market cap of $96.74 Billion USD ( CA$133.73 Billion CAD).
- Blackstone Group Inc (NYSE:BX): Ranked #270 globally with a market cap of $94.90 Billion USD.
- KKR & Co. Inc. (NYSE:KKR): Ranked #291 globally with a market cap of $89.37 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #135 | BlackRock Inc | NYSE:BLK | $167.86 Billion | $1090.39 |
| #266 | Brookfield Corporation | TO:BN | $96.74 Billion | CA$59.58 |
| #270 | Blackstone Group Inc | NYSE:BX | $94.90 Billion | $127.75 |
| #291 | KKR & Co. Inc. | NYSE:KKR | $89.37 Billion | $101.43 |
Applied DNA Sciences, Inc. Historical Marketcap From 2025 to 2026
Between 2025 and today, Applied DNA Sciences, Inc.'s market cap moved from $8.85 Million to $ 720.44K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $720.44K | -91.86% |
| 2025 | $8.85 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 2nd, 2026 the market cap of Applied DNA Sciences, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $720.44K USD |
| MoneyControl | $720.44K USD |
| MarketWatch | $720.44K USD |
| marketcap.company | $720.44K USD |
| Reuters | $720.44K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Applied DNA Sciences, Inc.
BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic m… Read more